|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:CEO
|
gptkb:Thierry_Bernard
|
|
gptkbp:countryOfOrigin
|
gptkb:Germany
|
|
gptkbp:foundedIn
|
1984
|
|
gptkbp:founder
|
gptkb:Detlev_Riesner
gptkb:Hans-Joachim_Schäfer
gptkb:Jürgen_Schumacher
gptkb:Metin_Colpan
|
|
gptkbp:headquartersLocation
|
gptkb:Hilden,_Germany
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
QIAGEN
|
|
gptkbp:industry
|
gptkb:biotechnology
|
|
gptkbp:ISIN
|
NL0012169213
|
|
gptkbp:legalForm
|
gptkb:public_company
|
|
gptkbp:market
|
healthcare
academic research
pharmaceutical industry
applied testing
|
|
gptkbp:notableProduct
|
gptkb:QIAcube
gptkb:QIAstat-Dx
QIAamp DNA Mini Kit
QuantiFERON
|
|
gptkbp:numberOfEmployees
|
over 6000
|
|
gptkbp:officeLocation
|
gptkb:Hilden,_Germany
|
|
gptkbp:parentCompany
|
QIAGEN N.V.
|
|
gptkbp:product
|
molecular diagnostics
life sciences research tools
sample and assay technologies
|
|
gptkbp:researchInterest
|
genomics
infectious diseases
oncology
precision medicine
molecular diagnostics
|
|
gptkbp:revenue
|
$2.14 billion (2022)
|
|
gptkbp:servesArea
|
worldwide
|
|
gptkbp:stockExchange
|
gptkb:New_York_Stock_Exchange
gptkb:Frankfurt_Stock_Exchange
|
|
gptkbp:stockSymbol
|
gptkb:QIA
|
|
gptkbp:subsidiary
|
gptkb:QIAGEN_Sciences
QIAGEN Manchester
|
|
gptkbp:website
|
https://www.qiagen.com/
|
|
gptkbp:bfsParent
|
gptkb:Citylabs_2.0
gptkb:CLC_Genomics_Workbench
|
|
gptkbp:bfsLayer
|
7
|